Algeria Gene Detection Technology Center



Image credit

We worked on a 25,000-words Simplified Chinese to English business proposal for the construction of a National gene detection technology application demonstration center in Algeria.

It consisted of a background study and statistical data of birth defects, genetic diseases leading to disabilities, and rising incidences of major illnesses in Algeria; contributing enormous strains to individual families and the society. It proposed that advances made in China and abroad in the biotechnology and genetics industry could help detect and treat illnesses by the 4P medical model – preventive medicine, predictive medicine, personalized medicine, and participatory medicine.


The proportion of newborn deafness in Algeria is around 1 % -3 %, and among more than 3,000 cases of newborn deafness each year, around 60% is caused by genetic factors. The incidence of Down syndrome is about 1/800-1/600, accounting for 70% -80% chance of occurrence in pediatric trichomes chromosome diseases, bringing serious economic strain to the community and causing enormous psychological pressure and mental stress on the family. At the same time, along with rapid economic and social development, incidences of cancer, cardiovascular disease, and other major diseases have shown a sharp upward trend.


Recent years has seen the international community highly valuing the progress made in the biotechnology and genetics industry, with special attention focused on expanding genetics testing technology to play a large-scale role in the screening of genetic diseases, cancer, and other major diseases, in individualized diagnosis and in other applications. A series of policies to support the industry in application development, prevention and treatment have been issued.


The genetic testing industry has gradually moved into a rapid development growth cycle. Within the genetics industry right now, genetic testing can be readily utilized with a broad range of applications, evolving into a business that can benefit human health. Since the complete implementation of the Human Genome Project (HGP) people’s understanding of genes has gradually deepened, genetic detection technology has rapidly developed, with the genetic testing industry chain gradually coming together. There are more and more genetic testing techniques moving from clinical research to clinically confirmed, mainly reflected in areas of disease risk prediction, assisting in the diagnosis of diseases, and providing guidance in health management and personalized care services.


In 1978, the famous Chinese American scientist Jane Yue Wei and colleagues used liquid-phase DNA molecular hybridization to successfully carry out genetic diagnosis on sickle cell anemia, marking the birth of genetic testing, resulting in a revolution in the field of disease diagnosis. In 1998, the United States officially launched the gene chip program, enabling quicker and easier gene screening. On June 22, 2000, the human genome plan sketch was completed. At the end of 2005, 454 Company launched the first high-throughput genome sequencing system based on the principle of pyrosequencing. In September 2013, Illumina’s MiseqDx platform passed the U.S. FDA’s technical certification for the first time as an open platform allowing capsule fibrosis reagent products to enter clinical use, marking the day that after 10 years of development, high-throughput sequencing technology has evolved from a pure science research platform into the field of clinical diagnosis.


With the development of gene detection technology in developed countries like Europe and America, the gene market has begun to take shape. Not only do a large number of professional companies provide genetic testing services, there are a few that develop gene repair drugs, research and develop, produce and sell genetic food.

随着基因技术和健康理念的发展,现代医学进入“4P”医学模式(4pmedicalmodel):1.预防医学(Preventive Medicine);2.预测医学(Predictive Medicine);3.个体医学(Personalized Medicine);4.参与医学(Participatory Medicine)。“4P”医学模式以解决慢性病问题为首要目标。

With the development of genetic technology and healthcare concepts, modern medicine enters a “4P” medical model (4pmedicalmodel): 1. Preventive Medicine; 2. Predictive Medicine; 3. Personalized Medicine; 4. Participatory Medicine. The “4P” Medical model aims to solve the problem of chronic diseases as its primary objective.


Preventive medicine involves multi-tiered actions: Foremost is people taking the initiative to prevent certain diseases through their own health habits; second tier is government policy intervention to encourage people taking proactive actions towards disease prevention through public policies, and making preventive medicine knowledge universal in order to improve the level of disease prevention across the community; the third tier is people choosing a green eco-city, embracing a low-carbon lifestyle through changing their environment.


The emergence of preventive medicine in the medical industry has seen “disease-cure” become an inevitable “macro health management” trend. In 2013, U.S. movie star Angelina Jolie had double mastectomy surgery performed to reduce her cancer risks after learning the results of her gene sequencing. Similar to her mother and aunt, she carried the BRCA1, BRCA2 gene, signifying she had a higher risk of developing ovarian cancer and breast cancer. To avoid this risk, Angelina had proactively made a preventive treatment, reducing her risk of developing breast cancer from 87% to 5%. This kind of preventive medicine based on genetic sequencing may very likely become a trend. In 2011, a survey of 1,463 respondents in the United States found that many people were willing to undergo predictive testing of diseases, with 76% of these 1,463 respondents willing to test for Alzheimer’s disease, breast cancer, prostate cancer, or arthritis. Respondents’ answers vary with the type, cost, and predictive accuracy of different diseases. The highest willingness was for prostate cancer (87%), followed by breast cancer (81%), and Alzheimer’s (72%).


Individualized diagnosis and treatment, gene detection, diagnosis, and treatment have entered the era of personalized medicine, using technology as the core disease diagnostic platform is the main direction of gene detection technology applications. The 2004 Nobel Prize winner Aaron Chernovo said that from now on we will enter a new “personalized medical” era. Future treatment options will be tailored to patient’s information. In recent years, individualized medicine, represented by gene sequencing, early screening of cancer and regenerative medicine, is ascending: In clinical practice, gene detection technology improves therapeutic results by detecting disease gene in diagnosis, clarifying the root cause, identifying drug-related gene markers, reducing medical costs; a 70-year-old Japanese female patient with exudative age-related macular degeneration underwent iPS cell transplantation, the surgery was the world’s first, marking it an important step forward using iPS cell in regenerative medicine.


With the improvement of people’s self-awareness and health concept in the modern society, more and more patients have evolved from passively allowing doctors decide their treatment methods, to taking a more proactive role to initiate and participate in the maintenance of their own health. Not only do these types of participation encourage patients to have more interaction with their doctors during the course of disease diagnosis and treatment, it also improves patients’ drug compliance, with the objective to improve people’s health management concept on the whole. People will gradually realize that fine, micro health management, such as temperature and blood glucose monitoring for women, etc., will improve their overall health condition and doctor’s visit experience. The way to a cure depends on the doctor, but not getting sick, a lot of times, depends on one’s own behavior and decisions.

We further worked on the technology and application for detections of the following diseases, the construction model of the center, and investment details. The content was meticulously researched to ensure its accuracy. Our client was happy with our efforts.


Molecular genetic disease detection, cancer molecular detection, cardiovascular and cerebrovascular diseases molecular detection, molecular detection of infectious and other diseases. Mainly providing genetic deafness gene detection, Down syndrome gene detection, neonatal genetic metabolic disease tandem mass spectrometry screening, chromosome karyotype analysis and FISH detection, chromosomal abnormalities detection, thalassemia detection, other single gene disease detection, hereditary cancer gene detection, tumor-related virus gene detection, plasma miRNA marker detection, breast cancer prognosis gene detection, leukemia fusion gene detection, multiple myeloma gene detection, individualized cancer drug detection, individualized cardiovascular and cerebrovascular disease drug detection, human papillomavirus (HPV) typing, hepatitis molecular diagnostics, detection of mycobacteria, other infectious diseases.

Large, technical translation. Nice work Bonnie – Ken, Los Angeles


Invest in a Care Home

Photo by Trang Doan from Pexels

We worked on both English to Traditional Chinese and English to Simplified Chinese brochure translations for a care home investment based in U.K. in 2017. Ran by an impressive operations team “recognized and approved by commissioners, inspectorates, the National Health Service (NHS), and social services”, the team has been commissioned to manage projects and provide care homes for hedge funds, worldwide investment groups, overseas hospitals, and governments.”


The brochure provided detailed information on market analysis, how to invest, investment benefits, opportunities, exit strategies, complete with FAQ.

Market Analysis*


Why invest in UK care homes?


Britain’s population is ageing. In 2012 the number of people aged 65 and older surpassed 10m for the first time; they now outnumber those aged 16 and under.

英國人口正在老化。 2012年,65歲及以上的人數首次超過1000萬; 他們的人數現超過16歲及以下的人。

The over 85 age group is now the fastest growing demographic in the UK, as we all live longer through improvements in health, diet and preventative care. Over the next 20 years the age group is set to grow by 106%, to over 2.6m people.


This trend will be accelerated over the coming decades by the inevitable retirement of the so-called ‘baby boomer’ generation (born when Britain experienced a markedly higher birth rate between 1946 and 1964). Those born at this time are now beginning to reach retirement age and are set to have a dramatic effect on the people, society, and the economy of the UK.


With this dramatic population change comes an increasing demand for specialist dementia and nursing care. There are currently over 800,000 people living with dementia -a figure that will rise to 1m by 2021, and more than double by 2050.

隨著這人口急劇增長,專營老人癡呆症和護理的需求日益增加。目前有80多萬人患有老人癡呆症 – 這個數字到2021年將會上升到100萬,到2050年將增加一倍以上。

Significantly, the number of people of working age supporting our ageing population – known as the ‘dependency ratio’ – is moving in the opposite direction; declining from 4 people per retiree at present to 2.5 by 2035 and 2 by 2050.


It is clear, therefore, that the care home market has a significant and central role to play in our future society, with increasing demand for high quality accommodation, care, and funding.


“The combined market value for care for older people in the UK is currently estimated to be worth £22.2bn, of which £13.4bn is attributable to residential care and £8.8bn to nonresidential care.”


“As the number of elderly people with high care needs in the UK is expected to increase significantly over the next 20 years, there will be a growing need for modern, fit-for-purpose care homes.”


“There are over 400,000 people living in care homes in the UK, and around 80,000 units in existing care home stock are reaching obsolescence.”


Sources: ONS, Age UK, Alzheimer’s Society, Royal Geographic Society


Your Benefits


  • Excellent return on investment (8 -12% per annum) GUARANTEED Buy-back options (3, 5 ,9,15 & 25 years)
  • 優質投資回報(每年8-12%)保證回購期權(3,5,9,15及25年)
  • Recession-proof investment – assessed care is inevitably required Room variants depending on investment level (£75,000 and up) Ethical investment
  • 抗經濟衰退投資 – 評估護理是必不可少的,房間變化取決於投資水平(£75,000及以上)道德投資
  • Demand for beds expected to exceed 40,000 by 2020 High demand locations
  • 預計到2020年,床鋪需求將超過4萬,高需求地點
  • Specialised fit-for-purpose buildings & equipment Qualified & experienced management teams Skilled & trained workforce
  • 專門,以目標為本的建築及設備,合資格及經驗豐富的管理團隊,熟練及訓練有素的員工隊伍
  • Multi-faceted specialist service offerings (residential, nursing, dementia & mental health, and learning disability)
  • 多範疇專門服務(住宿,護理,老人癡呆症,精神健康以及學習障礙人士)
  • Fully assessed and bespoke care packages
  • 全面評估和定制護理計劃
  • Design for Dementia*
  • 設計專門給患老人癡呆症人士*
  • Individual, fully managed care homes
  • 個人化,完全管理的護理院舍

Through working on this project, we have learned tons of information on home care for the elderly, the health and daily challenges an elderly person may face, the aging population that is growing rapidly all over the world, the investment opportunities inherent with the “silver hair” population, and the buying power of the “grey pound”.

We had done due diligence researching on the professional qualifications of the health team personnel, and on dementia and palliative care. Our client was happy with our efforts.

“The translation was very good and returned in good time.” – Rohan, U.K.

Strategic Cooperation Framework Agreement

Image credit

We worked on a Simplified Chinese to English strategic partnership agreement translation last month. The agreement focused on facilitating the sharing of professional advantages and resources between a digital content creation, production business based in Beijing and a CG-related, animation business based in Amsterdam.


Party A is a professional organization that engages in digital content business whose professional reputation is highly esteemed in mainland China. Party B is a professional organization that engages in digital content business with extensive customer resources outside China.


Both parties A and B seek to establish a close-knit business alliance by integrating their technical and resource advantages in their respective professional fields, thereby enhancing the competitiveness of individual or both parties, in providing quotations and delivering services to their existing or potential customers.


Both Parties A and B confirm that: During the cooperation period, either party as each other’s partner, upon accepting the invitation from the business contracted party, may participate in the contracted business, applying resources such as technology and equipment, by way of joint offering, both parties could provide project owners with better products and service.


The areas of mutual business cooperation between the two parties, on a global scale, will involve animation production, game CG, theme park-related content, VFX post-production, large-scale special events, and so on. Such content may be adjusted following supplementary consultation and negotiation from both parties in the future.


Both parties A and B will share all relevant proposals in production case scenarios for an owner’s project during the cooperation period, to ensure the necessary flow of business activities and employment of unified external communication.

The agreement highlighted the benefits, rights, and responsibilities of the strategic alliance between two businesses that were established in their fields. We learned a lot of new content in digital creation, VFX post-production, and theme park management. Our client was happy with our work.

“True professional work, very responsive, quick turnaround time, will definitely work with Bonnie again.” – Jianchao, Beijing


Legal, Tax, Accounting & Fiduciary


Image credit

We worked on a 6000-words English to Simplified Chinese business brochure translation for a Malta-based set of boutique legal, tax, accounting & fiduciary firms, with associated barristers chambers in March 2017.

The business brochure was comprehensive, spanning from an overview of Malta, its strategic location, EU membership, to setting up a trust and applying for its citizenship and residency programs.

The Republic of Malta a full EU member since 2004 is strategically located to provide services to the international community. Malta an English speaking country, has built upon the commercial laws of England and now the EU, to position itself as a premier family wealth, corporate and financial services jurisdiction.

马耳他共和国自2004年起便成为正式欧盟成员国,具备策略位置,为国际社会提供服务。 马耳他是英语国家,建基于英国,现今的欧盟商业法律,并本身定位成为首要的家庭财富,企业和金融服务管辖权。

With robust, competitive taxation rules, Malta has achieved sustained economic growth. Such growth is not solely the result of Malta’s tax and fiscal policies – there are other important factors such as multilingual workforce, lower labour costs, a strategic location and a sound telecommunications infrastructure.

马耳他拥有健全,具竞争性的税务规条,实现了持续的经济增长。 这增长不仅仅是马耳他税务和财政政策的果效 – 还有其他重要因素,如多语言的劳动人口,低劳动成本,策略位置和良好的电信基础设施等。

  • Credit Ratings – Moody A3, Fitch A, Standard and Poor BBB
  • 信用评级 – 穆迪A3,惠誉A,标准普尔BBB
  • Mixed common and civil law system – corporate, commercial and trusts laws based upon English statutes and EU
  • 混合普通法和大陆法系统 – 公司法,商业法及信托法,建基于英国和欧盟法规

Trusts, Confidentiality, and Tax Treatment.

Uniquely for an essentially civil law jurisdiction, Malta has succeeded, by virtue of the Trusts and Trustees Act 2004, in implementing the common law concept of trusts into its judicial and legislative systems.


Trusts may be established for either private or charitable purposes. Private trusts may exist for a period of 25 years.

信托可以因私人或慈善目的而设立。 私人信托可以存在25年。

In terms of the Trusts and Trustees Act, a trust may be established in a number of ways, although usually by an instrument in writing i.e. deed, or will. A trust may also come into existence by oral declaration, by operation of law, or judicial decision.

根据“信托和受托人法”,可以通过多种方式建立信托,尽管通常采用书面形式的文书,即契约或遗嘱。 信托也可以通过口头申报,通过法律操作或司法决定而成立。

Although trust property is settled on trust with the trustee, the trust is not a legal entity and does not have a legal personality separate from that of the trustee; compare with the distinct legal personality of a company, foundation, or family trust company.

虽然信托财产是根据与受托人的信托结算,但该信托并非法律实体,并且不具有与受托人分开的法人资格; 与公司,基金或家族信托公司的独特法人资格有分别。

As a highly regulated jurisdiction, Malta has a number of laws such as Professional Secrecy Act, the Trusts and Trustees Act and the Code of Ethics (Trustees) aimed at protecting the confidentiality of trusts and foundations.


Any necessary disclosure as to the terms of a foundation or trust instrument – for instance so as to satisfy a court judgment, or in respect of the trustee’s/ administrator’s duties towards the settlor or beneficiaries of a trust – is carefully crafted so, if necessary, only the minimum disclosure occurs in order to satisfy any such legitimate interest or order.

对基金或信托文书的任何必要披露 – 如为满足法院的判决,或就受托人/管理人对信托的委托人或受益人的职责,须作出必要的披露, 将谨慎谋划只作出最低限度的披露,以满足任何此类合法利益或命令。

Trusts & foundations may opt for either:


  1. Tax Transparent & Exempt – both trusts and foundations may be tax transparent – income is ‘looked through’ – and is exempt from tax in the hands of non-resident beneficiaries and resident trustees; subject to all of their income arising outside of Malta and all beneficiaries being either not ordinarily resident in and/or not domiciled in Malta; or

1.税务透明及豁免 – 信托及基金均享有透明税务 – 收入会被“看略” – 即在非居民受益人及居留受托人手中是免税的; 凡所有收入来自马耳他境外,而受益人通常不居留在马耳他和/或不居住在马耳他; 或

  1. Treated as a Company & Tax Refunds – for tax purposes both foundations and trusts may opt to be treated like a Maltese company, thereby enjoying the tax refund scheme (i.e. 5% effective corporate tax rate). Additional benefits will apply: access to Malta’s 70+ tax treaty network. Malta’s participation exemption – ensuring tax efficient extraction of subsidiary income from other jurisdictions.

2.作为公司处理退税 – 出于税收目的,基金及信托可选择像马耳他公司的相同对待,从而享受退税计划(即5%的有效公司税率)。 其他优惠将适用:享有马耳他70多项税务条约网络。 马耳他的参与豁免 – 确保有效的税务,收入提取自其他司法管辖区的子公司。

The brochure was exhaustive with information. We further worked on topics such as the benefits of setting up a Maltese company, double taxations, full imputation system, aviation, funds, financial services, EU passports, and Brexit.

The opportunity was a precious learning experience as we have to do extensive research on the different types of trusts, foundations and their workings to ensure the translation was accurate. We were thrilled that our client was happy with our work.

Excellent work, will use again! – Geraldine, Malta